BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 9695935)

  • 21. The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II.
    Ceda GP; Davis RG; Rosenfeld RG; Hoffman AR
    Endocrinology; 1987 Apr; 120(4):1658-62. PubMed ID: 3104015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in GHRH binding and GHRH receptor mRNA in the pituitary of adult dw/dw rats.
    Gardi J; Speth RC; Taishi P; Kacsóh B; Obál F; Krueger JM
    Peptides; 2002 Aug; 23(8):1497-502. PubMed ID: 12182953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.
    Kineman RD; Teixeira LT; Amargo GV; Coschigano KT; Kopchick JJ; Frohman LA
    Endocrinology; 2001 Sep; 142(9):3764-73. PubMed ID: 11517152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased GH Secretion and Body Growth in Mice Carrying Ablation of IGF-1 Receptor in GH-releasing Hormone Cells.
    Gusmao DO; de Sousa ME; Tavares MR; Donato J
    Endocrinology; 2022 Oct; 163(11):. PubMed ID: 36099517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
    Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of growth hormone (GH) gene expression and secretion during pregnancy and lactation in the rat: role of insulin-like growth factor-I, somatostatin, and GH-releasing hormone.
    Escalada J; Sánchez-Franco F; Velasco B; Cacicedo L
    Endocrinology; 1997 Aug; 138(8):3435-43. PubMed ID: 9231798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone regulation in primary fetal and neonatal rat pituitary cell cultures: the role of thyroid hormone.
    Ezzat S; Laks D; Oster J; Melmed S
    Endocrinology; 1991 Feb; 128(2):937-43. PubMed ID: 1989871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations of adenylyl cyclase-coupled growth hormone-releasing hormone (GHRH) pituitary receptors in different conditions of GHRH deprivation.
    Qing Y; Parenti M; Guzzi F; Ceresoli G; Müller EE; Cocchi D
    Brain Res; 1994 Apr; 644(1):13-8. PubMed ID: 8032940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of brain insulin-like growth factor I (IGF-I) binding sites and hypothalamic GHRH and somatostatin levels by exogenous growth hormone and IGF-I in juvenile rats.
    Eshet R; Gil-Ad I; Apelboym O; Segev Y; Phillip M; Werner H
    J Mol Neurosci; 2004; 22(3):179-88. PubMed ID: 14997011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of somatostatin-28 on growth hormone response to growth hormone-releasing hormone--impact of aging and lifelong dietary restriction.
    Shimokawa I; Higami Y; Okimoto T; Tomita M; Ikeda T
    Neuroendocrinology; 1997 May; 65(5):369-76. PubMed ID: 9158069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severity of the catabolic condition differentially modulates hypothalamic expression of growth hormone-releasing hormone in the fasted mouse: potential role of neuropeptide Y and corticotropin-releasing hormone.
    Luque RM; Park S; Kineman RD
    Endocrinology; 2007 Jan; 148(1):300-9. PubMed ID: 17038558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
    Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA
    Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
    Park S; Peng XD; Frohman LA; Kineman RD
    Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels.
    Yamashita S; Melmed S
    Endocrinology; 1986 Jan; 118(1):176-82. PubMed ID: 3079701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone.
    Bondanelli M; Ambrosio MR; Margutti A; Franceschetti P; Zatelli MC; degli Uberti EC
    Neuroendocrinology; 2003 Jun; 77(6):380-7. PubMed ID: 12845224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspects of the neuroendocrine control of growth hormone secretion in ageing mammals.
    Müller EE; Cella SG; De Gennaro Colonna V; Parenti M; Cocchi D; Locatelli V
    J Reprod Fertil Suppl; 1993; 46():99-114. PubMed ID: 8100277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic administration of a new potent agonist of growth hormone- releasing hormone induces compensatory linear growth in growth hormone-deficient rats: mechanism of action.
    Kovács M; Halmos G; Groot K; Izdebski J; Schally AV
    Neuroendocrinology; 1996 Sep; 64(3):169-76. PubMed ID: 8875434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly.
    Ikuyama S; Natori S; Nawata H; Kato K; Ibayashi H; Kariya T; Sakai T; Rivier J; Vale W
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1265-71. PubMed ID: 2836473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared with in vitro glucotoxicity.
    Bédard K; Strecko J; Thériault K; Bédard J; Veyrat-Durebex C; Gaudreau P
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E740-51. PubMed ID: 18285528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.